Precautions
Drug information provided by: Merative, Micromedex®
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood tests may be needed to check for unwanted effects at least every 2 weeks for the first 3 months during treatment with this medicine.
Using this medicine while you are pregnant can harm your unborn baby. If you are a woman who can get pregnant, your doctor may do tests to make sure you are not pregnant before starting treatment. Birth control pills may not work as well to prevent pregnancy when used with this medicine. Women should use another form of birth control (eg, condoms, spermicide) along with your pills for 2 months after the last dose. Male patients with female partners should use an effective form of birth control during treatment and for at least 2 months after the last dose. If a pregnancy occurs while using the medicine, tell your doctor right away.
Using this medicine may increase your risk of having a condition called differentiation syndrome, which may be life-threatening. It may occur within 10 days and during the first 5 months of treatment with this medicine. Check with your doctor right away if you start to have a fever, cough, shortness of breath, swelling of the arms or legs or around the neck, groin, or underarms, rapid weight gain, or bone pain.
This medicine may increase risk of a serious condition called tumor lysis syndrome. Your doctor may give you a medicine to help prevent this. Call your doctor right away if you have a decrease or change in urine amount, joint pain, stiffness, or swelling, lower back, side, or stomach pain, a rapid weight gain, swelling of the feet or lower legs, or unusual tiredness or weakness.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Portions of this document last updated: May 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.